|
Thursday, August 21 2008 |
|
Neptune Technologies & Bioressources Inc. announces the formation of an operating pharmaceutical subsidiary named Acasti Pharma Inc. Neptune structured part of its pharmaceutical operations into its subsidiary Acasti Pharma to carry out the research... |
|
Monday, August 11 2008 |
|
Neptune Technologies & Bioressources Inc. announces, in reference to and in payment of its dividend declared on July 17, 2008 to all its common shareholders registered as of July 28, 2008 in the aggregate amount of $9,380.36, the issuance of an aggregate of 9,380,355 notes... |
|
Thursday, July 17 2008 |
|
Neptune’s Board of Directors approved a dividend of $ 0.00025 CDN per share on the outstanding common shares of the Corporation for payment to shareholders of record at the close of business on July 28, 2008... |
|
Thursday, June 26 2008 |
|
Neptune Technologies & Bioressources Inc. and its commercial pharmaceutical partner Inovail Pty Ltd have made OmegaGen® Neptune Krill Oil, a complementary medicine, now widely available in Australia at the majority of pharmacy chains nationwide... |
|
Wednesday, June 11 2008 |
|
Neptune Technologies & Bioressources Inc. has been advised by its partner Schiff Nutrition International Inc. that Schiff® MegaRed™ containing Neptune Krill Oil has been listed as a permanent item in Costco in the United States... |
|
Tuesday, June 03 2008 |
|
Neptune Technologies & Bioressources Inc. entered into an agreement with Integrated Corporate Relations Inc. (“ICR”), a leading financial communications consulting firm specializing in investor relations and corporate communications... |
|
Monday, April 14 2008 |
|
Neptune Technologies & Bioressources Inc. today announced operational and financial results for the fiscal 2008 third quarter and nine-month period ended February 29, 2008 and provided an update on recent strategic milestones achieved... |
|
Wednesday, April 02 2008 |
|
Neptune Technologies & Bioressources Inc. and Croda Health Care, the worldwide leader in innovative specialty ingredients for nutritional and pharmaceutical health care markets, today announced the completion of a strategic commercialization alliance for North America and Europe... |
|
Thursday, March 27 2008 |
|
Neptune Technologies & Bioressources Inc. announces that the European Patent Office granted on May 31st 2007 Neptune’s composition of matter patent entitled “Natural Marine Source Phospholipids comprising flavonoïds, polyunsaturated fatty acids and their applications”... |
|
Tuesday, March 25 2008 |
|
Commercial pharmaceutical partner, Inovail, successfully launches OmegaGen® in Australia and New Zealand... |
|
|
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
|
